Drugs Made In America Acquisition II Corp. (DMII)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 22, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Cantor Fitzgerald & Co. to the SEC requests the acceleration of the effective date for the Registration Statement of Drugs Made In America Acquisition II C… | Read Filing EDGAR |
| Sep. 22, 2025 | CORRESP | Neutral/Informational | Moderate | Drugs Made In America Acquisition II Corp. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1. The company ac… | Read Filing EDGAR |
| Sep. 16, 2025 | CORRESP | Concern from SEC | Moderate | The correspondence from Drugs Made In America Acquisition II Corp. addresses comments from the SEC regarding their Registration Statement on Form S-1. The SEC raised concerns abou… | Read Filing EDGAR |
| Sep. 15, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has reviewed the amended registration statement for Drugs Made In America Acquisition II Corp. and has raised a comment regarding the transfer of founder shares to certain… | Read Filing EDGAR |
| Jul. 18, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Drugs Made In America Acquisition II Corp. addresses comments from the SEC regarding their Draft Registration Statement on Form S-1. The company has submit… | Read Filing EDGAR |